NuWave Investment Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1
Closed 299
2021
Q3
$0 Buy
+1
New +$286 ﹤0.01% 304
2021
Q2
Sell
-277
Closed -$108K 333
2021
Q1
$108K Buy
277
+85
+44% +$41.9K 0.14% 187
2020
Q4
$108K Buy
192
+82
+75% +$52K 0.14% 180
2020
Q3
$77K Sell
110
-41
-27% -$32K 0.12% 208
2020
Q2
$126K Buy
151
+32
+27% +$24.1K 0.17% 138
2020
Q1
$71K Buy
119
+76
+177% +$74.1K 0.15% 118
2019
Q4
$49K Sell
43
-18
-30% -$19.6K 0.05% 253
2019
Q3
$71K Buy
61
+49
+408% +$74.8K 0.07% 221
2019
Q2
$20K Buy
12
+11
+1,100% +$19K 0.02% 302
2019
Q1
$3K Sell
1
-86
-99% -$151K ﹤0.01% 347
2018
Q4
$111K Buy
87
+11
+14% +$16.9K 0.19% 145
2018
Q3
$143K Buy
76
+75
+7,500% +$155K 0.22% 153
2018
Q2
$1K Sell
1
-127
-99% -$289K ﹤0.01% 295
2018
Q1
$287K Buy
128
+69
+117% +$176K 0.45% 77
2017
Q4
$135K Buy
+59
New +$120K 0.16% 156

Other funds holding BLUE

NuWave Investment Management's BLUE Position: Q4 2021 in Review

NuWave Investment Management sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 1 share.

NuWave Investment Management first reported a position in BLUE in Q4 2017 and held it in 15 quarters. The position peaked at $287K in Q1 2018. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • NuWave Investment Management reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • NuWave Investment Management sold 1 bluebird bio share in Q4 2021.
  • NuWave Investment Management first reported a position in bluebird bio in Q4 2017 and held it in 15 quarters.
  • NuWave Investment Management's bluebird bio position peaked at $287K in Q1 2018.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on NuWave Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.